Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of $177.11 million as of July 15, 2025. Its market cap has increased by 3.46% in one year.

Market Cap

177.11M

Enterprise Value

224.69M

Revenue

53.20M

Ranking

n/a

PE Ratio

10.80

Stock Price

$12.00

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 257.00M to 177.11M, a decrease of -31.09%. That is a compound annual growth rate of -1.98%.

Market Cap History

Date	Market Cap	% Change
Jul 15, 2025	177.11M	-7.76%
Dec 30, 2024	192.01M	83.04%
Dec 29, 2023	104.90M	250.69%
Dec 30, 2022	29.91M	-5.41%
Dec 30, 2021	31.62M	-27.17%
Dec 30, 2020	43.42M	-62.90%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	840.66M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	567.50M
Nika Pharmaceuticals	554.26M
Glass House Brands	416.87M
CytoDyn	399.02M
Northwest Biotherapeutics	384.78M

Market Cap Rankings